Your browser doesn't support javascript.
loading
Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
Xu, J; Cai, M; Wang, Z; Chen, Q; Han, X; Tian, J; Jin, S; Yan, Z; Li, Y; Lu, B; Lu, H.
Afiliación
  • Xu J; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Cai M; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Wang Z; Department of Emergency, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Chen Q; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Han X; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Tian J; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Jin S; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Yan Z; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Li Y; Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, 200040, China.
  • Lu B; Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai, 200040, China.
  • Lu H; Department of Endocrinology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. luhao403@163.com.
J Endocrinol Invest ; 46(5): 869-882, 2023 May.
Article en En | MEDLINE | ID: mdl-36282471
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polineuropatías / Diabetes Mellitus Tipo 2 / Neuropatías Diabéticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polineuropatías / Diabetes Mellitus Tipo 2 / Neuropatías Diabéticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2023 Tipo del documento: Article País de afiliación: China